Exane Derivatives Zai Lab LTD Transaction History

Exane Derivatives

  • $157 Million
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022
SELL
$54.9 - $105.21 $59,895 - $114,784
-1,091 Closed
0 $0
Q3 2021

Oct 26, 2021
BUY
$105.0 - $178.37 $32,130 - $54,581
306 Added 38.98%
1,091 $114,000
Q2 2021

Jul 28, 2021
BUY
$125.11 - $180.0 $57,050 - $82,080
456 Added 138.6%
785 $138,000
Q1 2021

Apr 30, 2021
BUY
$126.27 - $191.71 $41,542 - $63,072
329 New
329 $43,000

Others Institutions Holding ZLAB

# of Institutions
116
Shares Held
40.8M
Call Options Held
63.1K
Put Options Held
420K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email